Snodgres Jon 4
4 · REPLIGEN CORP · Filed Aug 17, 2022
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
Snodgres Jon
CFO
Transactions
- Exercise/Conversion
Common Stock
2022-08-16$86.10/sh+3,047$262,347→ 40,234 total - Sale
Common Stock
2022-08-16$253.16/sh−2,400$607,584→ 34,506 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-08-16+970→ 1,940 totalExercise: $215.58Exp: 2031-02-24→ Common Stock (970 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-08-16+3,047→ 1,524 totalExercise: $86.10Exp: 2030-02-27→ Common Stock (3,047 underlying) - Exercise/Conversion
Common Stock
2022-08-16$215.58/sh+970$209,113→ 41,204 total - Sale
Common Stock
2022-08-16$252.70/sh−4,298$1,086,105→ 36,906 total
Footnotes (3)
- [F1]$252.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.16 to $253.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]1,524 shares vest and become exercisable on 2/27/2023.
- [F3]Shares vest and become exercisable as follows: 970 shares on 2/24/2023 and 970 shares on 2/24/2024.